F10 and viral infectious disease: Previous studies have demonstrated that FXa promotes viral infection by cleaving the SARS-CoV spike protein into its active components, suggesting that FXa inhibitors could potentially serve as effective antiviral agents (Al-Horani, 2020; Frydman et al., 2020; Kastenhuber et al., 2022) (Figure 4A).